MedTrace Logo

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

NCT00767494 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2012-09-19

No results posted yet for this study

Summary

The purpose of the study is to compare the IOP lowering efficacy of Travoprost/Brinzolamide dosed daily in the morning or evening, vs TRAVATAN dosed once daily in the evening, and vs. AZOPT dosed BID in patients with open-angle glaucoma or ocular hypertension.

Conditions

Interventions

DRUG

Travoprost/Brinzolamide fixed combination

Eye Drops, suspension once daily

DRUG

Azopt

Eye Drop Suspension, 1 drop BID

DRUG

Travatan

Eye Drop Solution, 1 drop BID

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767494 on ClinicalTrials.gov